Microbiological diagnosis and antibiotic therapy in patients with community-acquired pneumonia and acute copd exacerbation in daily clinical practice: Comparison to current guidelines

Lung

Volumn 191, Issue 3, 2013, Pages 239-246

  Reissig, Angelika ^a   Mempel, Christine ^b   Schumacher, Ulrike ^c   Copetti, Roberto ^d   Gross, Florian ^e   Aliberti, Stefano ^f  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b HELIOS KLINIKUM ERFURT   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d Latisana General Hospital   (Italy)

^e Department of Internal Medicine   (Germany)

^f UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Acute exacerbation of chronic obstructive pulmonary disease; Antibiotic therapy; Community acquired pneumonia; Guidelines; Microbiological diagnosis

Indexed keywords

AMINOPENICILLIN; ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; MACROLIDE; QUINOLONE DERIVATIVE;

ACUTE DISEASE; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BLOOD CULTURE; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMPARATIVE STUDY; DISEASE EXACERBATION; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FEMALE; HAEMOPHILUS INFLUENZAE; HOSPITAL PATIENT; HUMAN; INFECTION RISK; LEGIONELLA PNEUMOPHILA; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MORAXELLA CATARRHALIS; MULTICENTER STUDY; MYCOPLASMA PNEUMONIAE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SECONDARY ANALYSIS; SPUTUM ANALYSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; COMMUNITY-ACQUIRED INFECTIONS; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, BACTERIAL; EUROPE; FEMALE; GUIDELINE ADHERENCE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PNEUMONIA, BACTERIAL; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84878725248     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-013-9460-x     Document Type: Article

References (15)

1. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M et al (2011) Joint task force of the European respiratory society and European society for clinical microbiology and infectious diseases. Guidelines for the management of adult lower respiratory tract infections - full version. Clin Microbiol Infect 17(Suppl 6):1-59
2. Höffken G, Lorenz J, Kern W, Welte T, Bauer T, Dalhoff K et al (2009) Epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults. Guidelines of the Paul-Ehrlich-Society for Chemotherapy, the German Respiratory Society, the German Society for Infectiology and the competence network CAPNETZ Germany. Pneumologie 63:e1-e68
3. Global strategy for the diagnosis, management, and prevention of chronic obstuctive pulmonary disease. www.goldcopd.org. Accessed Feb 2013
4. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I et al (2009) Pneumonia guidelines committee of the BTS standards of care committee. BTS guidelines for the management of community acquired pneumonia in adults. Thorax 64(Suppl 3):1-55
5. National Institute for Health and Care Excellence, National Clinical Guideline Centre, Chronic Obstructive Pulmonary Disease (2010) Management of chronic obstructive pulmonary disease in adults in primary and secondary care (CG101). http://guidance.nice.org.uk/CG101
6. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC et al (2007) Infectious diseases society of America; American thoracic society (2007) Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27-S72
7. Celli BR, MacNee W, ATS/ERS Task Force (2004) Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 23:932-946
8. Reissig A, Copetti R, Mathis G, Mempel C, Schuler A, Zechner P et al (2012) Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia. A prospective multicentre diagnostic accuracy study. Chest 142:965-972
9. National Committee for Clinical Laboratory Standards (2004) Performance standards for antimicrobial susceptibility testing, 14th informational supplement. Approved standard M100-S14. Wayne, PA: National Committee for Clinical Laboratory Standards
10. Herrero FS, Olivas JB (2012) Microbiology and risk factors for community-acquired pneumonia. Semin Respir Crit Care Med 33:220-231
11. Welte T, Köhnlein T (2009) Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ network. Semin Respir Crit Care Med 30:127-135
12. Pletz MW, Rohde G, Schütte H, Bals R, von Baum H, Welte T (2011) Epidemiology and aetiology of community-acquired Pneumonia (CAP). Dtsch Med Wochenschr 136:775-780
13. Echols RM, Tillotson GS, Song JX, Tosiello RL (2008) Clinical trial design for mild-to-moderate community-acquired pneumonia - an industry perspective. Clin Infect Dis 47(Suppl 3):S166-S175
14. Aliberti S, Blasi F, Zanaboni AM, Peyrani P, Tarsia P, Gaito S (2010) Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia. Eur Respir J 36:128-134
15. Li JZ, Winston LG, Moore DH et al (2007) Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a metaanalysis. Am J Med 120:783-790